EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Treatment of residual disease following neoadjuvant therapy in breast cancer

Natalie K Heater, Khyati Somayaji, William Gradishar

Journal of Surgical Oncology · 2024-01 · 129 (1) · 18-25

DOI: 10.1002/jso.27523 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Surgical Oncology, online erschienen am 22.11.2023. Verfasst von Natalie K Heater und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, McGaw Medical Center of Northwestern University, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Substantial advances have been made in the systemic treatment of breast cancer with residual disease following neoadjuvant therapy. We reviewed recent and ongoing studies informing the standard clinical management of residual disease by subtype: HER2+, TNBC, and HR+/HER2‐, as well as strategies for BRCA+ disease. We conclude with a discussion of ongoing clinical trials and current controversies regarding the treatment of residual disease in breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleNeoadjuvant TherapyAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantErb-b2 Receptor Tyrosine KinasesNeoplasm, Residual

Stichwörter der Autor:innen

adjuvant therapybreast cancerpostneoadjuvantresidual cancer burdenresidual disease

Substanzen

Erb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Department of Medicine, McGaw Medical Center of Northwestern University, Chicago, Illinois, USA.
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA.

Zitieren

APA

Heater, N. K., Somayaji, K., & Gradishar, W. (2024). Treatment of residual disease following neoadjuvant therapy in breast cancer. Journal of Surgical Oncology, 129(1), 18-25. https://doi.org/10.1002/jso.27523

Vancouver

Heater NK, Somayaji K, Gradishar W. Treatment of residual disease following neoadjuvant therapy in breast cancer. Journal of Surgical Oncology. 2024;129(1):18-25. doi:10.1002/jso.27523

BibTeX
@article{Heater2024,
  author = {Heater, Natalie K and Somayaji, Khyati and Gradishar, William},
  title = {Treatment of residual disease following neoadjuvant therapy in breast cancer},
  journal = {Journal of Surgical Oncology},
  year = {2024},
  volume = {129},
  number = {1},
  pages = {18--25},
  doi = {10.1002/jso.27523}
}
Kostenlos starten →